Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.1550
-0.0050 (-3.13%)
Oct 8, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 313.81 million as of October 8, 2025. Its market cap has decreased by -53.25% in one year.
Market Cap
313.81M
Enterprise Value
250.06M
Revenue
5.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 313.81M, an increase of 2,458.72%. That is a compound annual growth rate of 42.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 313.81M | -60.31% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | 121.64M | 52.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.48B |
| Pro Medicus | 32.82B |
| Cochlear | 18.54B |
| Sonic Healthcare | 10.68B |
| Ramsay Health Care | 7.32B |
| Telix Pharmaceuticals | 5.21B |
| Ansell | 4.67B |
| Mesoblast | 3.53B |